{"id":"NCT00109031","sponsor":"Swedish Orphan Biovitrum","briefTitle":"Palifermin for the Reduction of Oral Mucositis in Single-dose Evaluation (PROMISE)","officialTitle":"A Randomized, Blinded, Active-control Trial of Palifermin (rHuKGF) to Evaluate Oral Mucositis in Subjects With Hematologic Malignancies Undergoing Fractionated Total Body Irradiation (fTBI) and High Dose Chemotherapy With Autologous Peripheral Blood Progenitor Cell (PBPC) Transplantation","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2005-01","primaryCompletion":"2006-02","completion":"2010-12","firstPosted":"2005-04-25","resultsPosted":"2014-09-15","lastUpdate":"2014-09-15"},"enrollment":47,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"DOUBLE","primaryPurpose":"SUPPORTIVE_CARE"},"conditions":["Cancer","Lymphoma","Leukemia"],"interventions":[{"type":"DRUG","name":"palifermin","otherNames":["Kepivance","Recombinant Human Keratinocyte Growth Factor (rHuKGF)"]},{"type":"RADIATION","name":"Total Body Irradiation","otherNames":[]},{"type":"DRUG","name":"Cyclophosphamide","otherNames":[]},{"type":"DRUG","name":"Etoposide","otherNames":["VP-16"]},{"type":"DRUG","name":"Placebo","otherNames":[]}],"arms":[{"label":"Palifermin 60 µg/kg for 3 days","type":"ACTIVE_COMPARATOR"},{"label":"Palifermin 180 μg/kg on Day -1","type":"EXPERIMENTAL"},{"label":"Palifermin 180 μg/kg on Day -2","type":"EXPERIMENTAL"},{"label":"Palifermin 180 μg/kg on Day -3","type":"EXPERIMENTAL"}],"summary":"To evaluate whether palifermin (rHuKGF) administered as a single dose is non-inferior to 3 consecutive doses of palifermin in reducing the incidence of severe oral mucositis (World Health Organization \\[WHO\\] grade 3 and 4).","primaryOutcome":{"measure":"Number of Participants With Severe Oral Mucositis (WHO Grade 3 and 4)","timeFrame":"Up to Day 28","effectByArm":[{"arm":"Palifermin 60 µg/kg for 3 Days","deltaMin":9,"sd":null},{"arm":"Palifermin 180 μg/kg on Day -1","deltaMin":6,"sd":null},{"arm":"Palifermin 180 μg/kg on Day -2","deltaMin":4,"sd":null},{"arm":"Palifermin 180 μg/kg on Day -3","deltaMin":9,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":3,"exclusionCount":8},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":1,"n":10},"commonTop":["Diarrhoea","Nausea","Vomiting","Fatigue","Rash"]}}